Foundation Medicine (FMI) Tops Q4 EPS by 12c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Foundation Medicine Announces 2015 Fourth Quarter and Year-End Results, Recent Highlights and 2016 Outlook
February 23, 2016 4:01 PM ESTCAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine (NASDAQ: FMI) today reported financial and operational results for the fourth quarter and year ended December 31, 2015. Highlights for the quarter and year included:
Fourth quarter revenue of $26.1 million, 39% year-over-year growth; 8,286 clinical tests reported in the fourth quarter, 15% year-over-year growth; Full year 2015 revenue of $93.2 million, 53% year-over-year growth; 32,998... More